Tetratherix Limited (ASX:TTX)

Market Cap	257.89M
Revenue (ttm)	2.00M +157.2%
Net Income	-11.97M
EPS	-0.31
Shares Out	50.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,957
Average Volume	6,016
Open	5.08
Previous Close	4.92
Day's Range	5.00 - 5.08
52-Week Range	2.88 - 5.80
Beta	n/a
RSI	61.81
Earnings Date	May 22, 2026

About Tetratherix

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Employees: 15
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TTX

Financial Performance

In fiscal year 2025, Tetratherix's revenue was 1.05 million, an increase of 21.88% compared to the previous year's 863,651. Losses were -9.43 million, 269.1% more than in 2024.